acute decompensate chronic heart failure
Conditions
Interventions
Group A:Huangqi injection
Group B:5% glucose injection
Sponsors
Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 75 years; 2. ADCHF patients, heart function NYHA III-IV; 3. The main symptom is decomposition; 4. LVEF<=40% is proved by ultrasonic cardiogram; 5. Elevator blood BNP (Brain Natriuretic Peptide); 5. Informed written consent was obtained from every participant before data collection; 6. with deficiency of vital energy.
Exclusion criteria
Exclusion criteria: 1. severe arrhythmia: degree II type II atrioventricular block or degree III atrioventricular block, ventricular tachycardia, sick sinus syndrome, frequent supraventricular tachycardia; (exclude patients after cadiac pacing therapy); 2. hypertrophic cardiomyopathy, restrictive cardiomyopathy, infective endoarditis, hyponutrition cardiomyopathy, pericardial tamponade, acute myocarditis, arcula cordis diseases; 3. acute myocardial infarction diagnosed in one week; 4. severe primary lung diseases (such as ARDS, COPD, pulmonary embolism, or pulmonale etc.); 5. other severe uncontrolled diseases of different systems; 6. alergy to investigational drug or never used investigational drug and with history of hyperacuity; 7. with severe mental sickness; 8. children, pregnant and breast feeding period woman.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tei index by UCG; LVEF by UCG; BNP; etc.; | — |
Countries
China
Contacts
Public ContactHuicong Xu
Outcome results
None listed